P

Priyanka

Active Director Director DIN 11221142
DIN 11221142 First appointment Aug 2025 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Aug 2025
Shareholding value Locked Premium profile

About Priyanka

Priyanka has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Meritime Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 11221142
Primary Designation Director
First Appointment 01 Aug 2025
Oldest Company Age 4 yrs

Current companies

Company Designation Appointment Founded Status
Meritime Pharma Private Limited U24290DL2022PTC399965
Director 01 Aug 2025 2022 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Meritime Pharma Private Limited
Premium access

Shareholding and investment profile for Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Priyanka

Priyanka has 1 years in corporate governance. Holds Director role. Currently with 1 company, including Meritime Pharma Private Limited. Engaged in General Business. Contributes to corporate operations.

Priyanka is associated with 1 company as Director.

Priyanka has expertise in General Business.

Priyanka has 1 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available